Moderna Makes Entrance with $40M Round for mRNA Work
Moderna Therapeutics emerged from stealth mode with a $40 million financing led by Flagship Ventures and a consortium of private investors. Moderna is developing a platform technology for delivery of messenger RNA (mRNA) to stimulate production of therapeutic proteins in the cells.
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST